Cosmos Health (NASDAQ:COSM) Shares Break Above 50-Day Moving Average – Time to Sell?

Cosmos Health Inc. (NASDAQ:COSM) passed above its fifty day moving average during trading on Friday. The stock has a fifty day moving average of $0.30 and traded as high as $0.31. Cosmos Health shares last traded at $0.3079, with a volume of 2,068,763 shares.

Analysts Set New Price Targets

Several research firms recently commented on COSM. Weiss Ratings reiterated a “sell (d-)” rating on shares of Cosmos Health in a research note on Wednesday. Noble Financial began coverage on Cosmos Health in a report on Monday, October 26th. They issued an “outperform” rating on the stock. One equities research analyst has rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Hold”.

Cosmos Health Trading Up 11.0%

The company has a debt-to-equity ratio of 0.15, a current ratio of 1.05 and a quick ratio of 0.92. The business has a 50 day simple moving average of $0.30 and a 200 day simple moving average of $0.31. The company has a market cap of $30.98 million, a price-to-earnings ratio of -0.48 and a beta of 4.69.

Cosmos Health (NASDAQ:COSM) last released its quarterly earnings results on Tuesday, August 18th. The company reported ($0.10) EPS for the quarter, hitting analysts’ consensus estimates of ($0.10). The company had revenue of $19.32 million for the quarter, compared to analyst estimates of $18.99 million. Cosmos Health had a negative return on equity of 56.88% and a negative net margin of 33.08%. As a group, equities analysts forecast that Cosmos Health Inc. will post -0.15 EPS for the current year.

Institutional Trading of Cosmos Health

An institutional investor recently raised its stake in Cosmos Health stock. Renaissance Technologies LLC raised its stake in shares of Cosmos Health Inc. (NASDAQ:COSM) by 16.7% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 390,500 shares of the company’s stock after acquiring an additional 55,925 shares during the period. Renaissance Technologies LLC owned about 0.75% of Cosmos Health worth $124,000 as of its most recent SEC filing. Institutional investors own 12.61% of the company’s stock.

Cosmos Health Company Profile

Cosmos Health Inc is a healthcare group that develops, manufactures and distributes pharmaceutical, nutraceutical and healthcare products. Its portfolio includes branded dietary supplements, vitamins and wellness products, as well as pharmaceutical products and medical devices distributed through retail, wholesale and online channels.

The company markets its nutraceutical products under the Sky Premium Life brand, which offers supplements and other health and wellness products. Cosmos Health also has manufacturing and product-development activities through Cana Laboratories, a Greece-based pharmaceutical manufacturer that produces pharmaceutical and healthcare products for its own portfolio and third parties.

Founded in 2009 and formerly known as Cosmos Holdings, the company adopted the Cosmos Health name in 2022.